Insurers get a 2.48% MA pay bump after close call with a flat rate
Medicare Advantage plans will receive a 2.48% payment increase for 2027, a significant boost from the previously proposed 0.9% and following intense lobbying from insurers. This decision by CMS also largely sidesteps further risk adjustment changes, giving insurers more time to adapt to prior updates. While an improvement, the finalized rate is still below the 4-6% increase many insurers anticipated amidst rising medical costs and waning MA participation.
CVS Stock Rises After CMS Medicare Advantage Update
CVS Health stock is up after the Centers for Medicare & Medicaid Services (CMS) announced an average 2.48% increase in Medicare Advantage payments for 2027, totaling over $13 billion. This update is significant for CVS due to its Aetna insurance unit and managed-care exposure, despite CMS maintaining the 2024 risk-adjustment model and excluding certain diagnoses from risk-score calculations. Investors are focusing on the funding boost ahead of the company's Q1 earnings report on May 6th, with analysts maintaining a bullish bias on the stock.
RBC Capital Adjusts Karyopharm Therapeutics PT to $16 From $23, Maintains Outperform Rating
RBC Capital has adjusted its price target for Karyopharm Therapeutics (KPTI) to $16 from $23, while maintaining an Outperform rating. This change comes shortly after news of Karyopharm Therapeutics Inc. expecting to receive $29.999661 million in funding from RA Capital Management, L.P. The company also recently reported positive topline results from its Phase 3 SENTRY trial in Myelofibrosis.
Keefe Bruyette & Woods Adjusts Cincinnati Financial PT to $190 From $191, Maintains Outperform Rating
Keefe Bruyette & Woods has revised its price target for Cincinnati Financial Corporation (CINF) to $190, down from $191, while reiterating an "Outperform" rating on the stock. This adjustment reflects a slight change in the analyst's valuation, though the positive outlook on the property & casualty insurer remains. The article also provides recent news and financial details about Cincinnati Financial.
Daytona Street Capital LLC Invests $2.69 Million in CVS Health Corporation $CVS
Daytona Street Capital LLC has acquired a new position of 33,888 shares in CVS Health Corporation, valued at approximately $2.69 million, making it their 16th largest holding. This investment comes as CVS reported strong Q4 results, exceeding EPS and revenue estimates, and announced a quarterly dividend of $0.665. Analysts maintain a "Moderate Buy" rating for CVS with an average target price of $94.95.
Fulton Breakefield Broenniman LLC Has $14.87 Million Stock Position in UnitedHealth Group Incorporated $UNH
Fulton Breakefield Broenniman LLC reduced its stake in UnitedHealth Group (UNH) by 8.3% in Q4, now holding 45,041 shares valued at $14.87 million. The healthcare conglomerate is experiencing positive sentiment due to a larger-than-expected Medicare Advantage payment increase for 2027, boosting its revenue outlook. Analysts maintain a "Moderate Buy" rating with a target price of $363.38, while the company anticipates Q1 earnings on April 21st.
Canaccord Genuity Initiates Tyra Bioscience at Buy With $50 Price Target
Canaccord Genuity has initiated coverage on Tyra Biosciences (TYRA) with a "Buy" rating and a price target of $50. This positive analyst recommendation follows several other firms, including Wedbush, Oppenheimer, and Barclays, also raising price targets or initiating coverage on the biotechnology company in recent months. Tyra Biosciences is focused on developing precision medicines for Fibroblast Growth Factor Receptor (FGFR) biology, with lead product candidate TYRA-300 in Phase 1 clinical study.
UnitedHealth Group Incorporated Trade Ideas — LS:869561
This article compiles various trading ideas and analyses for UnitedHealth Group (UNH), highlighting both technical and fundamental perspectives. Several traders suggest bullish long positions based on technical indicators like bullish reversal patterns, demand zones, and moving average crossovers, while others emphasize UNH's strong fundamentals as a diversified healthcare giant. The article also includes an AI analysis of insider buying patterns for UNH and other companies, and offers different trade plans with entry, stop loss, and take profit targets.
Morgan Stanley Lowers Price Target on MetLife to $89 From $93, Keeps Overweight Rating
Morgan Stanley has adjusted its price target for MetLife (MET) to $89, down from the previous $93, while maintaining an "Overweight" rating on the stock. This update reflects a revised valuation perspective from the firm. The article also mentions recent MetLife developments including executive appointments and changes in S&P 100 listing.
DGX Stock News Today | Earnings, Events & Price Alerts
This article provides recent news and event updates for Quest Diagnostics (DGX), including their upcoming Q1 2026 financial results announcement and the launch of an AI companion for lab data analysis. It also highlights leadership appointments, dividend increases, and stock performance milestones for the company.
The Cigna Group's First Quarter 2026 Earnings Release Details
The Cigna Group (NYSE: CI) will release its first quarter 2026 financial results on Thursday, April 30, 2026, and will host a conference call on the same day. Financial results will be available by 6:30 a.m. ET, with a management review call beginning at 8:30 a.m. ET. A live internet webcast of the call will also be available, and a replay will be accessible until May 14, 2026.
1 Value Stock to Keep an Eye On and 2 We Avoid
This article identifies one value stock, Cigna (CI), as a promising investment due to its strong revenue growth and earnings performance, while advising against First Financial Bancorp (FFBC) and Autoliv (ALV) due to muted growth, slower demand, and higher production costs. The analysis highlights the challenge of distinguishing genuinely undervalued companies from "value traps" and emphasizes the importance of strong fundamentals in value investing.
The Cigna Group's First Quarter 2026 Earnings Release Details
The Cigna Group announced it will release its first quarter 2026 financial results on Thursday, April 30, 2026, no later than 6:30 a.m. ET. The company will host a conference call at 8:30 a.m. ET on the same day to review these results, with details provided for live call and replay access, as well as a live internet webcast. Financial news release and supplement will be available on their investor relations website.
Northfield Bancorp : Looking for a New Career Opportunity? Northfield Bank is Hiring - Meet us on April 14!
Northfield Bank is hosting a hiring event on Tuesday, April 14th, from 10:00 AM to 3:00 PM at 575 Mill Road, Staten Island, NY 10306. The bank, which has served the community for over a century, is seeking passionate and customer-focused individuals to join its team. Interested candidates can walk in or schedule an appointment by contacting DeAnna Gleco, Human Resources Generalist.
Goldman Sachs Adjusts Price Target on Equifax to $192 From $208, Maintains Neutral Rating
Goldman Sachs has adjusted its price target for Equifax (EFX) to $192 from $208, while maintaining a Neutral rating on the stock. This revision comes as part of ongoing analyst evaluations of the professional information services company. Other financial firms have also recently updated their price targets for Equifax, reflecting dynamic market conditions and company performance.
The Cigna Group's First Quarter 2026 Earnings Release Details
The Cigna Group (NYSE:CI) announced it will release its first quarter 2026 financial results on Thursday, April 30, 2026, by 6:30 a.m. ET. A conference call hosted by management to review these results will take place on the same day at 8:30 a.m. ET. Details for live dial-in and webcast access are provided for investors and interested parties.
Cigna posts Q1 results by 6:30 a.m. ET, holds investor call April 30
The Cigna Group (NYSE: CI) announced it will release its first quarter 2026 financial results on April 30, 2026, by 6:30 a.m. ET. Management will host a conference call to discuss these results at 8:30 a.m. ET, with a live webcast and replay available. This announcement continues the company's established practice of pre-announcing earnings logistics, with historical data showing an average -5.52% stock move following previous earnings-tagged events, despite often positive fundamentals.
Cancer screening rates dip in US as cost concerns deter access
A new survey by the Prevent Cancer Foundation indicates that nearly three-quarters of U.S. adults are behind on routine cancer screenings, a 4% increase from the previous year. Financial strain, particularly concerns about unexpected costs and potential follow-up tests, is a major contributing factor, even though initial screenings are often covered as preventive care. Additionally, a lack of patient education, logistical barriers, and flagging trust in the healthcare industry are also hindering screening rates.
Tidemark Capital, Inc., General Atlantic Service Company, L.P., Hg Saturn 1 managed by HgCapital LLP completed the acquisition of OneStream, Inc. (NasdaqGS:OS) from Tidemark Capital, Inc. and KKR & Co. Inc..
Tidemark Capital, Inc., General Atlantic Service Company, L.P., and Hg Saturn 1 (managed by HgCapital LLP) have completed their acquisition of OneStream, Inc. for approximately $6 billion. Hg will become the majority shareholder, with OneStream's stock delisted. The acquisition was supported by a $1.4 billion loan from Blue Owl Capital and received unanimous approval from OneStream's Board and KKR & Co. Inc.
Bernstein Bullish on The Cigna Group (CI) Amid Leadership Change and Improved Backdrop
Bernstein has upgraded The Cigna Group (CI) from "Market Perform" to "Outperform" with a $358 price target, citing factors like PBM reform, FTC settlement, and new PBM model changes. This optimism follows a leadership change where Brian Evanko will succeed CEO David Cordani, a move that prompted differing analyst opinions regarding its timing amidst the company's multi-year PBM transformation. Despite potential risks, analysts largely hold bullish ratings on Cigna, expecting its valuation multiple to expand.
New Era Energy & Digital, Inc. and Stream Data Centers Enter Joint Venture For Texas Critical Data Centers Campus
New Era Energy & Digital, Inc. and Stream Data Centers have formed a joint venture to develop and finance a critical data centers campus in West Texas. New Era will contribute its site and local relationships, while an institutional investor will provide equity capital and source debt financing, and Stream Data Centers will handle development, leasing, and operations. This partnership allows New Era to maintain a significant stake in the venture, generating recurring revenue through its capital-efficient platform strategy.
Meyer Handelman Co. Lowers Stock Position in Cigna Group $CI
Meyer Handelman Co. significantly reduced its stake in Cigna Group by 53.5% in the fourth quarter, selling 5,982 shares and leaving 5,193 shares valued at approximately $1.43 million. This institutional adjustment comes amidst recent insider selling by Nicole S. Jones and Everett Neville, who collectively sold over 4,000 shares. Despite these divestments, Cigna reported strong Q4 results, surpassing analyst estimates for EPS and revenue, and analysts maintain a "Moderate Buy" consensus rating with an average target price of $333.11 for the health services provider.
Aprea Therapeutics Announces Closing of Oversubscribed $30 Million Private Placement
Aprea Therapeutics, Inc. has successfully closed an oversubscribed private placement, raising approximately $30 million. This financing, led by Soleus Capital with participation from other new and existing investors, will be used for general corporate purposes and to accelerate the clinical development of its lead oncology asset, APR-1051. The company plans to expand the evaluation of APR-1051 in specific biomarker-defined cancer populations, including uterine serous carcinoma and platinum-resistant ovarian cancer.
MFS Charter Income Trust announces Monthly dividend, payable on April 30, 2026
MFS Charter Income Trust has announced a monthly dividend of $0.0440 per share, which will be payable on April 30, 2026. The ex-date and record date for this dividend are both set for April 14, 2026. The Fund's primary objective is to seek high current income by investing primarily in debt instruments.
Vivos Therapeutics’ Supported Practices Achieve In-Network Status in Nevada
Vivos Therapeutics announced that physician-owned practices it supports in Nevada have achieved in-network status with major commercial insurers and Medicare, significantly expanding patient access to its obstructive sleep apnea treatments. This development is expected to boost medical referrals and increase revenue in the Las Vegas market. Concurrently, Vivos is implementing cost-reduction initiatives in its legacy dental distribution model, anticipating $4 million in annual savings to help the company achieve cash flow positivity in fiscal year 2026.
Certain Performance Share Units of Alignment Healthcare, Inc. are subject to a Lock-Up Agreement Ending on 1-APR-2026.
Certain Performance Share Units (PSUs) of Alignment Healthcare, Inc. (ALHC) will conclude their 30-day lock-up period on April 1, 2026. This lock-up, starting March 2, 2026, prevents directors and executive officers from disposing of or hedging common stock or convertible securities. The agreement aims to stabilize the stock price after a recent offering.
Progyny (NASDAQ: PGNY) schedules virtual 2026 meeting; board, audit ratification on ballot
Progyny (NASDAQ: PGNY) has scheduled its 2026 virtual annual meeting for May 21, 2026, with a record date of March 27, 2026, and 78.3 million shares outstanding. Stockholders will vote on the election of three Class I directors, ratification of Ernst & Young LLP as the independent auditor, an advisory vote on executive compensation, and two amendments to the Certificate of Incorporation to eliminate certain supermajority voting requirements. The proposed amendments aim to streamline governance by changing the voting threshold for several corporate actions from two-thirds to a simple majority of outstanding shares.
Celebrating Cigna Healthcare Singapore's 15 years of connected, world-class healthcare #CignaHealthcareSingapore
Cigna Healthcare Singapore is celebrating its 15th anniversary with a year-long campaign themed "Celebrating 15 years of Connected, World-class Healthcare." The company, which dominates Singapore's premium healthcare market, is highlighting its global connectivity and support for member health through various initiatives, including digital advertisements and internal employee well-being programs. Cigna Healthcare Singapore is also addressing medical inflation by partnering with iXchange on value-based contracts and evolving its Cigna Care Connect program to offer more domestically focused solutions.
FatPipe And TD SYNNEX Enter Distribution Agreement
FatPipe, Inc. has partnered with TD SYNNEX, a global IT solutions distributor, to expand the reach of its networking and cybersecurity solutions. This collaboration aims to make FatPipe's secure SD-WAN, SASE, WAN optimization, network security, and cybersecurity portfolio more accessible to enterprise partners and customers worldwide. The partnership is expected to broaden FatPipe's sales footprint and help organizations simplify network management, improve performance, and strengthen cybersecurity in distributed and cloud-driven environments.
IShares Trust - iShares ESG Aware USD Corporate Bond ETF announces Monthly dividend, payable on April 07, 2026
The iShares Trust - iShares ESG Aware USD Corporate Bond ETF has declared a monthly dividend of USD 0.0878 per share. This dividend is payable on April 07, 2026, with an ex-date and record date set for April 01, 2026. The announcement was published on March 30, 2026, according to S&P Capital IQ.
TRNR Reports Record Full-Year 2025 Results, Driven by 114% Revenue Growth; Confirms 2026 Guidance of $30M+ in Pro Forma Revenue & $0.5M Stock Repurchase Program
Interactive Strength Inc. (TRNR) reported record full-year 2025 revenue of $11.5 million, a 114% year-over-year increase, alongside a net loss of $24.0 million. The company reaffirmed its 2026 guidance, projecting over $30 million in pro forma revenue, significantly boosted by the full consolidation of Wattbike and the recent acquisition of Ergatta, which is expected to contribute over $10 million in revenue. TRNR also announced a $0.5 million stock repurchase program, representing approximately 19% of its outstanding shares, and aims to achieve run-rate profitability within the next twelve months.
Sprott Focus Trust Insider Bought Shares Worth $1,209,868, According to a Recent SEC Filing
An insider at Sprott Focus Trust, Inc. purchased shares valued at $1,209,868, according to a recent SEC filing. The company, a Canada-based diversified closed-end investment fund, focuses primarily on long-term capital growth by investing at least 65% of its assets in equity securities, with a particular emphasis on small-cap and micro-cap companies in the United States. This insider transaction comes as the fund reported its full-year earnings for 2025 and declared its first-quarter 2026 common stock distribution.
Dolly Varden Silver Corporation(TSXV:DV) dropped from S&P/TSX Venture Composite Index
Dolly Varden Silver Corporation (TSXV:DV) has been removed from the S&P/TSX Venture Composite Index. This news follows a series of recent corporate activities, including Contango Ore, Inc. completing the acquisition of Dolly Varden Silver Corporation on March 26th. The company had previously reported its full-year earnings for 2025 and announced several significant drilling results.
Elevance Health, Inc. Experiences Valuation Adjustment Amidst Market Dynamics and Peer Comparison
Elevance Health, Inc. has adjusted its valuation, with its stock price at $286.39, down from $294.25, and a 33.70% decline over the past year, contrasting with the S&P 500's positive return. Key financial metrics include a P/E ratio of 11, an EV to EBITDA of 39.15, a dividend yield of 2.42%, and an ROE of 12.90%. The adjustment reflects broader market trends and the company's performance compared to peers like Cigna Group and UnitedHealth Group, highlighting the dynamic nature of the healthcare services industry.
Raymond James Financial Issues Positive Forecast for Suncor Energy (TSE:SU) Stock Price
Raymond James Financial has increased its price target for Suncor Energy (TSE:SU) from C$76.00 to C$93.00, suggesting a potential upside of 0.81%. This positive forecast aligns with other analysts who have also raised their price targets for the company. Suncor Energy recently reported C$1.10 earnings per share and C$12.04 billion in revenue for the quarter.
Cogent Biosciences, Cigna Group among top healthcare stocks, according to UBS analysts
UBS analysts have identified several top healthcare stock picks, emphasizing companies with underappreciated earnings durability and significant upcoming catalysts. Cogent Biosciences (NASDAQ:COGT) is highlighted in biotech for its late-stage assets and blockbuster potential, while Cigna Group (NYSE:CI) is favored in managed care due to a valuation disconnect and expected earnings growth. Other picks include CVS Health Corp, Merck & Co Inc, United Therapeutics Corporation, and CG Oncology, all chosen for strategic reasons like recovery stories, pipeline strength, or asymmetric upside potential.
Cbl & Associates Properties, Inc. Approves Special Cash Dividend for First Quarter of 2026, Payable on April 17, 2026
Cbl & Associates Properties, Inc. announced a special cash dividend of $0.175 per common share for the first quarter of 2026, payable on April 17, 2026. This special dividend, combined with the previously declared $0.45 per share dividend, brings the total first-quarter dividend to $0.625 per share, marking a 39% increase. The company plans to incorporate this increase into its regular quarterly dividend starting in the second quarter, leading to an annualized rate of $2.50 per common share, subject to Board approval.
UnitedHealth Group Incorporated Stock: AI Innovation and Earnings in Focus Amid Healthcare Pressures
UnitedHealth Group is focusing on AI innovation with the recent launch of its AI companion Avery, aiming to streamline benefits navigation and administrative tasks for members. Despite this technological advancement and a resilient integrated healthcare model, its shares are facing near-term challenges and trading below key moving averages ahead of its Q1 2026 earnings report. Investors are keenly watching the upcoming earnings for insights into Medicare Advantage trends, cost controls, and Optum's performance, balancing growth potential against regulatory pressures and market volatility.
Healthcare Services Group, Inc. (NASDAQ:HCSG) Given Consensus Rating of "Hold" by Analysts
Healthcare Services Group (NASDAQ:HCSG) has received a consensus "Hold" rating from nine financial analysts, with an average 12-month price target of $22.00. Insider selling activity was noted, with executives disposing of a significant number of shares in February, totaling approximately $3.01 million in the last quarter. Despite the "Hold" rating, the company exceeded EPS expectations in its last quarterly report, posting $0.44 per share against an estimated $0.23, though revenue was largely in line with forecasts at $466.68 million.
Nuveen AMT Free Quality Municipal Income Fund : Six Nuveen Closed-End Funds Announce Availability of 19(a) Notices - March 27, 2026
Nuveen has announced the availability of 19(a) distribution notices for six of its closed-end funds (CEFs), including the Nuveen AMT-Free Quality Municipal Income Fund. These notices provide detailed information on the sources of the funds' regular quarterly distributions, highlighting that a portion of the distributions for several funds may be a return of capital. Shareholders are advised that this information is for informational purposes only and not for tax reporting, with official tax documents to follow.
Elevance Health (NYSE: ELV) 2026 proxy outlines 2025 growth, pay and ESG
Elevance Health's 2026 proxy statement details robust 2025 financial performance, including $197.6 billion in operating revenue and $6.8 billion in adjusted net income, alongside returning $4.1 billion to shareholders. The company emphasizes its whole health strategy, strong governance with independent board oversight, and commitments to ESG initiatives, including AI governance, fair pay, and environmental sustainability. Shareholders will vote on director elections, executive compensation, auditor ratification, and a proposal regarding corporate political contributions at the virtual annual meeting on May 13, 2026.
Express Scripts Just Got Sued for Racketeering. Here’s What That Means.
Express Scripts, a pharmacy benefit manager (PBM) owned by Cigna, is facing a class-action lawsuit for racketeering. The lawsuit, filed by a powerhouse law firm representing thousands of employers and unions, alleges that Express Scripts created an offshore entity in Switzerland called Ascent to reclassify rebates as "fees" and avoid sharing them with clients, thereby siphoning money from employers, unions, and patients. This legal challenge, along with a recent FTC settlement, highlights alleged opacity and self-dealing within the PBM industry.
Cyabra Strategy Ltd. completed the acquisition of Trailblazer Merger Corporation I from a group of shareholders in a reverse merger transaction.
Cyabra Strategy Ltd. has successfully completed its acquisition of Trailblazer Merger Corporation I through a reverse merger transaction on March 27, 2026. This deal, valued at approximately $150 million, results in the combined entity operating as Cyabra, Inc., with its common stock expected to trade on Nasdaq under the ticker symbol CYAB starting March 27, 2026. The transaction involved complex negotiations and multiple extensions since its initial letter of intent in February 2024, with various financial and legal advisors facilitating the merger.
-3.14% for UnitedHealth stock as persistent bearish momentum drives fresh lows
UnitedHealth Group (UNH) stock declined 3.14% to $259.64, trading below key moving averages and indicating persistent bearish momentum due to regulatory and legal challenges. Analysts project a single-digit profit decline and $110.08 billion in sales for the upcoming quarter. Technical indicators confirm the bearish trend, with a high probability of further downside in the short term unless the stock decisively breaks above $281.
Wolfe Research Adjusts PT on FactSet Research Systems to $210 From $290, Keeps Underperform Rating
Wolfe Research has lowered its price target for FactSet Research Systems (NYSE: FDS) to $210 from $290, while maintaining an Underperform rating on the stock. This adjustment reflects a more cautious outlook from the research firm regarding FactSet's future performance. The article also lists other recent analyst recommendations and company news, including the launch of FactSet's beta AI-enabled document search function and various price target cuts from other firms.
First Trust Exchange-Traded Fund VIII - First Trust Flexible Municipal High Income ETF announces Monthly dividend, payable on March 31, 2026
First Trust Exchange-Traded Fund VIII - First Trust Flexible Municipal High Income ETF has declared a monthly dividend of USD 0.0600 per share. The dividend is payable on March 31, 2026, with an ex-date and record date set for March 26, 2026. This announcement highlights the ETF's consistent dividend distribution policy.
BMO hires Joe Kostandoff from CIBC for equities leadership role
Bank of Montreal has appointed Joe Kostandoff, formerly of CIBC, to co-lead its equity capital markets division. This move coincides with long-time leader Peter Miller transitioning into a vice-chair role within investment and corporate banking. Kostandoff is expected to join BMO in June, and Eric Benedict will continue as co-head of global ECM alongside him, both reporting to Carrie Cook.
Ascentage Pharma Group International posts FY loss increased to RMB1,243 million
Ascentage Pharma Group International reported a widening loss for the full fiscal year, reaching RMB1,243 million. This update comes alongside recent news regarding the company's progress in clinical trials and regulatory clearances for its drug candidates, including several IND clearances in both China and the US for BTK degrader APG-3288 and positive data presentations for Olverembatinib and Lisaftoclax. The company focuses on developing therapies for cancers, hepatitis B, and age-related diseases.
Insurers, Brokers Can't Exit Medicare Advantage Steering Suit
A Massachusetts federal judge has largely denied attempts by insurers and brokers to dismiss claims that they conspired in a kickback scheme. The lawsuit alleges that these entities steered Medicare Advantage customers to specific plans through illegal means, with the full article content being available to registered subscribers of Law360 Healthcare Authority.
The Cigna Group Appoints New Chief Medical Officer for Cigna Healthcare
Cigna Healthcare, the health benefits division of The Cigna Group, has appointed Dr. Stanley Crittenden as its new Chief Medical Officer. Dr. Crittenden will be responsible for leading the clinical organization, advancing initiatives for personalized, high-quality, and affordable care, and overseeing the evolution of clinical solutions and programs. His extensive background in managed care, clinical operations, and value-based care will support Cigna's efforts to simplify healthcare and improve patient outcomes.
